/2 Key messages from Dr. @tomcnguyen at #EACTS2020: We need to know the data well in order to have a productive conversation and advocate for what would be best for patients.
/3 Dr. @tomcnguyen provides a comprehensive over of what we know on #TAVR data to date at #EACTS2020
Need long term follow-up of trials as we move to lower risk cohorts.
Need long term follow-up of trials as we move to lower risk cohorts.
/7 Dr. @tomcnguyen on TAVR - embrace it but be aware of the creep. #EACTS2020
Do what is best for patients and know the data.
Do what is best for patients and know the data.